Medical Research News and Research

RSS

Allergan receives FDA approval for expanded use of LAP-BAND System in obese adults

Allergan, today announced the U.S. Food and Drug Administration approved the expanded use of the LAP-BAND System, Allergan's gastric band, for adults with obesity who have failed more conservative weight reduction alternatives, such as diet and exercise and pharmacotherapy, and have a Body Mass Index of 30-40 and at least one obesity related comorbid condition.

16 Feb 2011

Study explores role of proline containing peptides in inhibiting anti-apoptotic function of XIAP

Basic and translational research on cancer, and development of new cancer therapeutics, has focused on different aspects of cancer cellular function. One area of focus is the life and death of a cancer cell. Apoptosis, also known as programmed cell death, is a fundamental process of cells including cancer cells. The signal transduction pathways of apoptosis involve many different proteins and their interactions with each other.

16 Feb 2011

Combined chemotherapy and radiation therapy effective against Hodgkin's lymphoma, in the short term

Modern treatment for early stage Hodgkin's lymphoma is highly effective, leaving most patients with no evidence of cancer. However, experts differ on the best approach: Is chemotherapy enough or does adding radiation therapy improve the outcome?

16 Feb 2011

New study confirms effectiveness of inhaled epinephrine to treat croup

For more than 30 years, pediatricians have treated children who have croup with inhaled epinephrine to relieve their symptoms quickly. Now, a new review confirms the value of this approach to treat this common respiratory illness, which sometimes turns serious and - in rare instances - can prove fatal.

16 Feb 2011

Researchers identify cell of origin for sarcoma

Researchers at Oregon Health & Science University Doernbecher Children's Hospital have defined the cell of origin for a kind of cancer called sarcoma. In a study published today as the Featured Article in the journal Cancer Cell, they report that childhood and adult sarcomas are linked in their biology, mutations and the cells from which these tumors first start.

16 Feb 2011

Patients with chronic low-back pain can benefit from spinal manipulation

If you're suffering from chronic lower back pain, a new review of existing research finds that spinal manipulation − the kind of hands-on regimen that a chiropractor might perform on you − is as helpful as other common treatments like painkillers.

15 Feb 2011

New review of anthrax case discussed by review committee vice chair, Stanford bioterrorism expert

In 2001, a mystery perpetrator mailed a series of anthrax-laced letters to several locations, killing five people. In 2008, shortly after emerging as the prime suspect in an exhaustive investigation by the FBI, an Army microbiologist, Bruce Ivins, PhD, committed suicide. This morning, a National Academy of Sciences committee, charged in September 2008 with reviewing the scientific approaches used by the FBI in that investigation, released its report.

15 Feb 2011

Researcher discovers mechanism how p53 human genome gets inactivated in cancerous cells

One of the most important genes in the human genome is called p53 and its function is to suppress tumours, according to Roger Leng, a researcher in the Faculty of Medicine & Dentistry. Leng has discovered the mechanism by which p53 is inactivated in cancerous cells, allowing tumours to grow.

15 Feb 2011

ASU, Mayo sign agreement to broaden collaboration in health care, medical research and education

Mayo Clinic and Arizona State University have signed an agreement to broaden and deepen their collaboration in health care, medical research and education. The agreement is a formal commitment to enhance the relationship built over the past eight years.

15 Feb 2011

Registration open for idiopathic pulmonary fibrosis healthcare summit

The Pulmonary Fibrosis Foundation (PFF) announced today that registration is now open for the IPF Summit 2011: From Bench to Bedside. The conference will feature an innovative two-day continuing medical education (CME) program for physicians, researchers, and other health care professionals. Additionally there will be a separate one-day patient, family member, and caregiver program to address the growing educational needs of the idiopathic pulmonary fibrosis (IPF) community.

14 Feb 2011

Guide star and time-reversal mirror in biomedical imaging

Astronomers have a neat trick they sometimes use to compensate for the turbulence of the atmosphere that blurs images made by ground-based telescopes. They create an artificial star called a guide star and use its twinkling to compensate for the atmospheric turbulence.

11 Feb 2011

Neuralstem updates progress of ongoing clinical trial of spinal cord stem cells in treatment of ALS

Neuralstem, Inc. updated the progress of its ongoing Phase I human clinical trial of the company's spinal cord stem cells in the treatment of ALS (amyotrophic lateral sclerosis, or Lou Gehrig's disease) at Emory University in Atlanta, Georgia.

11 Feb 2011

TMJ Medical receives FDA postmarket surveillance study order

TMJ Medical acknowledged Tuesday receiving a postmarket surveillance study order from the U.S. Food and Drug Administration. TMJ Medical is one of three medical device manufacturers approved to market temporomandibular joint (TMJ) implants in the United States. Each manufacturer received the same FDA order.

10 Feb 2011

Vical 2010 net loss increases to $30.4 million

Vical Incorporated today reported financial results for the year ended December 31, 2010. Vical had cash and investments of approximately $61 million at year-end 2010. The company received approximately $37 million of net proceeds from the sale of equity securities during 2010.

10 Feb 2011

Akonni signs license agreement with USAMRIID to develop multiplex testing products for bio-security applications

Akonni Biosystems, a molecular diagnostics (MDx) company that develops rapid, low-cost and highly scalable solutions for infectious disease testing, today announced it has signed a license agreement with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID).

10 Feb 2011

Viewpoints: Abortion fight intensifies; Michelle Obama's anti-obesity crusade; Milken on research investment

For our servicewomen around the world, H.R. 3 reminds them that they must roll the dice with whatever local, non-U.S.-affiliated medical facility they can find.

10 Feb 2011

Targacept initiates TC-6987 Phase 2 study in patients with asthma, Type 2 diabetes

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today announced the initiation of separate Phase 2 clinical studies of its product candidate TC-6987 in disorders characterized by inflammation, one in asthma and one in Type 2 diabetes.

9 Feb 2011

BBSRC, EMBL-EBI applaud funding allocation for European Life-science Infrastructure for Biological Information

The Biotechnology and Biological Sciences Research Council (BBSRC) and the European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) welcome news that funding has been earmarked from the UK's Large Facilities Capital Fund for ELIXIR - the European Life-science Infrastructure for Biological Information - as announced today (09 February 2011).

9 Feb 2011

Gates Foundation awards USF $5.45M for malaria research

The University of South Florida received $5.45 million in grants from the Bill & Melinda Gates Foundation. The first grant is to create advanced devices that mimic the human liver to better study the life cycle of the malaria parasite - particularly the elusive liver stage where the disease may be most vulnerable to attack.

9 Feb 2011

Cancer cells emerge as ghosts from the past: Literally

Cancer is growing by the day worldwide and the cancer cells still manage to evade both the body’s defenses and medical intervention. Now an explanation to the phenomenon is provided by an Arizona State University scientist.

8 Feb 2011

Medical Research News and Research

Allergan receives FDA approval for expanded use of LAP-BAND System in obese adults

Study explores role of proline containing peptides in inhibiting anti-apoptotic function of XIAP

Combined chemotherapy and radiation therapy effective against Hodgkin's lymphoma, in the short term

New study confirms effectiveness of inhaled epinephrine to treat croup

Researchers identify cell of origin for sarcoma

Patients with chronic low-back pain can benefit from spinal manipulation

New review of anthrax case discussed by review committee vice chair, Stanford bioterrorism expert

Researcher discovers mechanism how p53 human genome gets inactivated in cancerous cells

ASU, Mayo sign agreement to broaden collaboration in health care, medical research and education

Registration open for idiopathic pulmonary fibrosis healthcare summit

Guide star and time-reversal mirror in biomedical imaging

Neuralstem updates progress of ongoing clinical trial of spinal cord stem cells in treatment of ALS

TMJ Medical receives FDA postmarket surveillance study order

Vical 2010 net loss increases to $30.4 million

Akonni signs license agreement with USAMRIID to develop multiplex testing products for bio-security applications

Viewpoints: Abortion fight intensifies; Michelle Obama's anti-obesity crusade; Milken on research investment

Targacept initiates TC-6987 Phase 2 study in patients with asthma, Type 2 diabetes

BBSRC, EMBL-EBI applaud funding allocation for European Life-science Infrastructure for Biological Information

Gates Foundation awards USF $5.45M for malaria research

Cancer cells emerge as ghosts from the past: Literally

A guide to advancing biotherapeutic research eBook

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Latest News